A healthy live birth after mosaic blastocyst transfer in preimplantation genetic testing for GATA1-related cytopenia combined with HLA matching.
GATA1
HLA typing
Mosaic blastocyst transfer
PGT-M
Journal
BMC medical genomics
ISSN: 1755-8794
Titre abrégé: BMC Med Genomics
Pays: England
ID NLM: 101319628
Informations de publication
Date de publication:
03 Jul 2024
03 Jul 2024
Historique:
received:
30
06
2023
accepted:
27
06
2024
medline:
4
7
2024
pubmed:
4
7
2024
entrez:
3
7
2024
Statut:
epublish
Résumé
GATA1-related cytopenia (GRC) is characterized by thrombocytopaenia and/or anaemia ranging from mild to severe. Haematopoietic stem cell transplantation (HSCT) is a healing therapeutic choice for GRC patients. We identified a novel pathogenic variant (GATA1: c.1019delG) in a boy with GATA1-related cytopenia. Then we performed preimplantation genetic testing (PGT) in this GRC family. After a mosaic embryo transfered, a healthy and HLA-compatible with the proband baby was delivered. The proband is a 6-year-old boy who was diagnosed to have transfusion-dependent anaemia since 3 year old. Whole-exome sequencing (WES) showed that the proband has a hemizygous variant c.1019delG in GATA1, which is inherited from his mother. His parents decided to undergo PGT to have a health and HLA-compatible offspring. After whole genome amplification (WGA) of biopsied trophectoderm (TE) cells, next generation sequencing (NGS)-based PGT was preformed to analyse embryos on chromosomal aneuploidy, target mutation and HLA typing. There were 3 embryos HLA-matched to the proband. The genotypes of the 3 embryos were heterozygous variant, hemizygous variant, normal respectively. After a heterozygous, mosaic partial trisomy (chr)16, and HLA-matched embryo transfer, a healthy baby was delivered and whose HSCT is compatible with the proband. NGS-based PGT-HLA is a valuable procedure for the treatment of GATA1-related cytopenia caused by GATA1 variants, or other haematological disorders, oncological and immunological diseases. Furthermore, our study reconfirms that mosaic embryos transfer would bring healthy offspring.
Sections du résumé
BACKGROUND
BACKGROUND
GATA1-related cytopenia (GRC) is characterized by thrombocytopaenia and/or anaemia ranging from mild to severe. Haematopoietic stem cell transplantation (HSCT) is a healing therapeutic choice for GRC patients. We identified a novel pathogenic variant (GATA1: c.1019delG) in a boy with GATA1-related cytopenia. Then we performed preimplantation genetic testing (PGT) in this GRC family. After a mosaic embryo transfered, a healthy and HLA-compatible with the proband baby was delivered.
CASE PRESENTATION
METHODS
The proband is a 6-year-old boy who was diagnosed to have transfusion-dependent anaemia since 3 year old. Whole-exome sequencing (WES) showed that the proband has a hemizygous variant c.1019delG in GATA1, which is inherited from his mother. His parents decided to undergo PGT to have a health and HLA-compatible offspring. After whole genome amplification (WGA) of biopsied trophectoderm (TE) cells, next generation sequencing (NGS)-based PGT was preformed to analyse embryos on chromosomal aneuploidy, target mutation and HLA typing. There were 3 embryos HLA-matched to the proband. The genotypes of the 3 embryos were heterozygous variant, hemizygous variant, normal respectively. After a heterozygous, mosaic partial trisomy (chr)16, and HLA-matched embryo transfer, a healthy baby was delivered and whose HSCT is compatible with the proband.
CONCLUSIONS
CONCLUSIONS
NGS-based PGT-HLA is a valuable procedure for the treatment of GATA1-related cytopenia caused by GATA1 variants, or other haematological disorders, oncological and immunological diseases. Furthermore, our study reconfirms that mosaic embryos transfer would bring healthy offspring.
Identifiants
pubmed: 38961467
doi: 10.1186/s12920-024-01951-2
pii: 10.1186/s12920-024-01951-2
doi:
Substances chimiques
GATA1 Transcription Factor
0
GATA1 protein, human
0
Types de publication
Journal Article
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
177Subventions
Organisme : The Key Medical Subject of Shenzhen
ID : （2020-2024）（SZXK031）
Organisme : The Research Program of Science, Technology and Innovation Commission of Shenzhen Municipality
ID : 2020231557
Informations de copyright
© 2024. The Author(s).
Références
Tang X-B, Liu D-P, Liang C-C. Regulation of the transcription factor GATA-1 at the gene and protein level: CMLS. Cell Mol Life Sci. 2001;58:2008–17.
doi: 10.1007/PL00000833
pubmed: 11814053
Crispino JD, Horwitz MS. GATA factor mutations in hematologic disease. Blood. 2017;129:2103–10.
doi: 10.1182/blood-2016-09-687889
pubmed: 28179280
pmcid: 5391620
Doshi BS, Abramowsky C, Briones M, Bunting ST. Concomitant a novel ALAS2 mutation and GATA1 mutation in a newborn: a case report and review of the literature. Am J Blood Res. 2014;4:41–5.
pubmed: 25232504
pmcid: 4165116
Karakurt N, Tavil B, Azik F, Tunc B, Karakas Z, Uckan-Cetinkaya D. Successful hematopoietic stem cell transplantation in a child with congenital erythropoietic porphyria due to a mutation in GATA-1. Pediatr Transplant. 2015;19:803–5.
doi: 10.1111/petr.12571
pubmed: 26392207
Takasaki K, Kacena MA, Raskind WH, Weiss MJ, Chou ST. GATA1-Related cytopenia. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, Gripp KW, et al., editors. GeneReviews®. Seattle: University of Washington; 1993.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
doi: 10.1038/gim.2015.30
pubmed: 25741868
pmcid: 4544753
He B, Wang L, Wu Q, Wang X, Ji X, Shi W, et al. Clinical application of NGS-based SNP haplotyping for PGT-M of methylmalonic acidemia. Syst Biol Reprod Med. 2022;68:80–8.
doi: 10.1080/19396368.2021.2005718
pubmed: 34913786
Masset H, Ding J, Dimitriadou E, Debrock S, Tšuiko O, Smits K, et al. Single-cell genome-wide concurrent haplotyping and copy-number profiling through genotyping-by-sequencing. Nucleic Acids Res. 2022;50:e63.
doi: 10.1093/nar/gkac134
pubmed: 35212381
pmcid: 9226495
Wang Y, Qin M, Yan Z, Guan S, Kuo Y, Kong S, et al. A strategy using SNP linkage analysis for monogenic diseases PGD combined with HLA typing. Clin Genet. 2020;98:138–46.
doi: 10.1111/cge.13770
pubmed: 32378203
Chen D, Shen X, Xu Y, Ding C, Ye Q, Zhong Y, et al. Successful four-factor preimplantation genetic testing: α- and β-thalassemia, human leukocyte antigen typing, and aneuploidy screening. Syst Biol Reprod Med. 2021;67:151–9.
doi: 10.1080/19396368.2020.1832158
pubmed: 33494632
Balaban B, Gardner DK. Morphological assessment of blastocyst stage embryos: Types of grading systems and their reported outcomes. In: Gardner DK, Sakkas D, Seli E, Wells D, editors. Human Gametes and Preimplantation Embryos. New York: Springer New York; 2013. p. 31–43.
Evans T, Reitman M, Felsenfeld G. An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc Natl Acad Sci USA. 1988;85:5976–80.
doi: 10.1073/pnas.85.16.5976
pubmed: 3413070
pmcid: 281888
Ludwig LS, Lareau CA, Bao EL, Liu N, Utsugisawa T, Tseng AM, et al. Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1. Blood. 2022;139:2534–46.
doi: 10.1182/blood.2021013753
pubmed: 35030251
pmcid: 9029090
Di Pierro E, Russo R, Karakas Z, Brancaleoni V, Gambale A, Kurt I, et al. Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis. Eur J Haematol. 2015;94:491–7.
doi: 10.1111/ejh.12452
pubmed: 25251786
Shimizu R, Yamamoto M. Gene expression regulation and domain function of hematopoietic GATA factors. Semin Cell Dev Biol. 2005;16:129–36.
doi: 10.1016/j.semcdb.2004.11.001
pubmed: 15659347
Campbell AE, Wilkinson-White L, Mackay JP, Matthews JM, Blobel GA. Analysis of disease-causing GATA1 mutations in murine gene complementation systems. Blood. 2013;121:5218–27.
doi: 10.1182/blood-2013-03-488080
pubmed: 23704091
pmcid: 3695365
Hwang D, Ishikawa LLW, Seyedsadr MS, Mari E, Kasimoglu E, Sahin Z, et al. GATA1 controls numbers of hematopoietic progenitors and their response to autoimmune neuroinflammation. Blood Adv. 2022;6:5980–94.
doi: 10.1182/bloodadvances.2022008234
pubmed: 36206195
pmcid: 9691916
Svidnicki MCCM, Filho MAF, Brandão MM, Dos Santos M, de Oliveira DR, Tavares RS, et al. New germline GATA1 variant in females with anemia and thrombocytopenia. Blood Cells Mol Dis. 2021;88:102545.
doi: 10.1016/j.bcmd.2021.102545
pubmed: 33611093
Verlinsky Y, Rechitsky S, Schoolcraft W, Strom C, Kuliev A. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA. 2001;285:3130–3.
doi: 10.1001/jama.285.24.3130
pubmed: 11427142
Xie P, Hu X, Kong L, Mao Y, Cheng D, Kang K, et al. A novel multifunctional haplotyping-based preimplantation genetic testing for different genetic conditions. Hum Reprod. 2022;37:2546–59.
doi: 10.1093/humrep/deac190
pubmed: 36066440
Fernández RM, Peciña A, Lozano-Arana MD, García-Lozano JC, Borrego S, Antiñolo G. Novel one-step multiplex PCR-based method for HLA typing and preimplantational genetic diagnosis of β-thalassemia. Biomed Res Int. 2013;2013:1–9.
doi: 10.1155/2013/585106
Korzebor A, Zamani M, Nouri K, Modarressi MH. Statistical analysis of six STR loci located in MHC region in Iranian population for preimplantation genetic diagnosis. Int J Immunogenet. 2007;34:441–3.
doi: 10.1111/j.1744-313X.2007.00719.x
pubmed: 18001301
ESHRE PGT-M Working Group, Carvalho F, Moutou C, Dimitriadou E, Dreesen J, Giménez C, et al. ESHRE PGT Consortium good practice recommendations for the detection of monogenic disorders†. Hum Reprod Open. 2020;2020:hoaa018.
doi: 10.1093/hropen/hoaa018
pmcid: 7257022
Chuang T-H, Chang Y-P, Lee M-J, Wang H-L, Lai H-H, Chen S-U. The incidence of mosaicism for individual chromosome in human blastocysts is correlated with chromosome length. Front Genet. 2021;11:565348.
doi: 10.3389/fgene.2020.565348
pubmed: 33488666
pmcid: 7815765
Wu L, Jin L, Chen W, Liu JM, Hu J, Yu Q, et al. The true incidence of chromosomal mosaicism after preimplantation genetic testing is much lower than that indicated by trophectoderm biopsy. Hum Reprod. 2021;36:1691–701.
doi: 10.1093/humrep/deab064
pubmed: 33860322
Xiao M, Lei C-X, Xi Y-P, Lu Y-L, Wu J-P, Li X-Y, et al. Next-generation sequencing is more efficient at detecting mosaic embryos and improving pregnancy outcomes than single-nucleotide polymorphism array analysis. J Mol Diagn. 2021;23:710–8.
doi: 10.1016/j.jmoldx.2021.02.011
pubmed: 33781963
Huang Q-X, Wang Z-H, Huang W-J, Mao L-H, Lin C-L, Chen G-Y, et al. Factors influencing mosaicism: a retrospective analysis. Reprod Biomed Online. 2022;45:491–500.
doi: 10.1016/j.rbmo.2022.04.020
pubmed: 35843780
Tarozzi N, Nadalini M, Lagalla C, Coticchio G, Zacà C, Borini A. Male factor infertility impacts the rate of mosaic blastocysts in cycles of preimplantation genetic testing for aneuploidy. J Assist Reprod Genet. 2019;36:2047–55.
doi: 10.1007/s10815-019-01584-w
pubmed: 31630313
pmcid: 6823398
Xiong S, Liu W, Wang J, Liu J, Gao Y, Wu L, et al. Trophectoderm biopsy protocols may impact the rate of mosaic blastocysts in cycles with pre-implantation genetic testing for aneuploidy. J Assist Reprod Genet. 2021;38:1153–62.
doi: 10.1007/s10815-021-02137-w
pubmed: 33660205
pmcid: 7929899
Coll L, Parriego M, Mateo S, García-Monclús S, Rodríguez I, Boada M, et al. Prevalence, types and possible factors influencing mosaicism in IVF blastocysts: results from a single setting. Reprod Biomed Online. 2021;42:55–65.
doi: 10.1016/j.rbmo.2020.09.025
pubmed: 33153932
Ai X, Shi Y, Liu L-W, Xu Y, Zhang H, Liu Y, et al. Risk factors related to chromosomal mosaicism in human blastocysts. Reprod Biomed Online. 2022;45:54–62.
doi: 10.1016/j.rbmo.2022.02.016
pubmed: 35550344
Greco E, Minasi MG, Fiorentino F. Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. N Engl J Med. 2015;373:2089–90.
doi: 10.1056/NEJMc1500421
pubmed: 26581010
Zhang YX, Chen JJ, Nabu S, Yeung QSY, Li Y, Tan JH, et al. The pregnancy outcome of mosaic embryo transfer: a prospective multicenter study and meta-analysis. Genes. 2020;11:973.
doi: 10.3390/genes11090973
pubmed: 32825792
pmcid: 7565393
Viotti M, Victor AR, Barnes FL, Zouves CG, Besser AG, Grifo JA, et al. Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use. Fertil Steril. 2021;115:1212–24.
doi: 10.1016/j.fertnstert.2020.11.041
pubmed: 33685629
Abhari S, Kawwass JF. Pregnancy and neonatal outcomes after transfer of mosaic embryos: a review. J Clin Med. 2021;10:1369.
doi: 10.3390/jcm10071369
pubmed: 33801687
pmcid: 8037456
Wang X, Zhao J, Yao Z, Xia Q, Chang T, Zeng J, et al. Arrested cells/cellular debris expelled from blastocysts is self-correction phenomenon during early embryonic development. Reprod Sci. 2023;30:2177–87.
doi: 10.1007/s43032-022-01159-8
pubmed: 36627481
Coorens THH, Oliver TRW, Sanghvi R, Sovio U, Cook E, Vento-Tormo R, et al. Inherent mosaicism and extensive mutation of human placentas. Nature. 2021;592:80–5.
doi: 10.1038/s41586-021-03345-1
pubmed: 33692543
pmcid: 7611644
Gleicher N, Patrizio P, Mochizuki L, Barad DH. Previously reported and here added cases demonstrate euploid pregnancies followed by PGT-A as “mosaic” as well as “aneuploid” designated embryos. Reprod Biol Endocrinol. 2023;21:25.
doi: 10.1186/s12958-023-01077-7
pubmed: 36890559
pmcid: 9993652
Kahraman S, Cetinkaya M, Yuksel B, Yesil M, Pirkevi CC. The birth of a baby with mosaicism resulting from a known mosaic embryo transfer: a case report. Hum Reprod. 2020;35:727–33.
doi: 10.1093/humrep/dez309
pubmed: 32155260
pmcid: 7105348
Huang K-L, Tsai C-C, Cheng H-H, Huang Y-J, Lai Y-J, Wu C-H, et al. Whether to transfer mosaic embryos: a cytogenetic view of true mosaicism by amniocentesis. Reprod Biomed Online. 2021;43:33–43.
doi: 10.1016/j.rbmo.2021.03.003
pubmed: 33962907
Schlade-Bartusiak K, Strong E, Zhu O, Mackie J, Salema D, Volodarsky M, et al. Mosaic embryo transfer—first report of a live born with nonmosaic partial aneuploidy and uniparental disomy 15. F S Rep. 2022;3:192–7.
pubmed: 36212558
pmcid: 9532879
Franasiak JM. Mosaic embryo transfer: a cautionary tale. F S Rep. 2022;3:179–80.
pubmed: 36212562
pmcid: 9532881